SEC Form 4 research
| Issuer | Larimar Therapeutics, Inc. |
|---|---|
| Tickers | ZFGN, LRMR |
| Reporting owners | 49 |
| Officers and directors | 20 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-29 | Harlow John B. Jr. | A | 50,000 | $0 | Not reported |
| 2026-10-01 | 2026-09-29 | Harlow John B. Jr. | A | 800,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.